Shenzhen Chipscreen Biosciences Co (SHSE:688321) Accounts Payable & Accrued Expense

: ¥145.4 Mil (As of Sep. 2022)

View and export this data going back to 2019. Start your Free Trial

Shenzhen Chipscreen Biosciences Co's quarterly accounts payable & accrued expense increased from Mar. 2022 (¥114.6 Mil) to Jun. 2022 (¥142.4 Mil) and increased from Jun. 2022 (¥142.4 Mil) to Sep. 2022 (¥145.4 Mil).

Shenzhen Chipscreen Biosciences Co's annual accounts payable & accrued expense increased from Dec. 2019 (¥69.4 Mil) to Dec. 2020 (¥109.7 Mil) and increased from Dec. 2020 (¥109.7 Mil) to Dec. 2021 (¥148.6 Mil).

Shenzhen Chipscreen Biosciences Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Shenzhen Chipscreen Biosciences Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Chipscreen Biosciences Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Accounts Payable & Accrued Expense

63.87

69.39

69.37

109.71

148.64

Shenzhen Chipscreen Biosciences Co Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Accounts Payable & Accrued Expense																120.65	148.64	114.63	142.38	145.42

Shenzhen Chipscreen Biosciences Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Shenzhen Chipscreen Biosciences Co (SHSE:688321) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Chipscreen Biosciences Co Ltd (SHSE:688321) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 10, Gaoxin Zhongyi, Room 601-606, Building 2, Shenzhen Biological Incubation Base, Gaoxin Zhongyi, Nanshan District, Guangdong, Shenzhen, CHN, 518057

Website

http://www.chipscreen.com

Shenzhen Chipscreen Biosciences Co Ltd is engaged in the research and development of small molecule drugs.

Shenzhen Chipscreen Biosciences Co (SHSE:688321) Headlines

No Headlines